Phase II evaluation of gallium nitrate in breast cancer: a Southwest Oncology Group Study.
D000970:Antineoplastic Agents / Q000633:toxicity*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005708:Gallium / Q000627:therapeutic use / Q000633:toxicity*; D006801:Humans; D009362:Neoplasm Metastasis
D000970:Antineoplastic Agents; D005708:Gallium; C027235:gallium nitrate